Trades on 1 secondary market

Clearlabs

Clear Labs builds fully automated next-generation sequencing (NGS) platforms and software for genomic analysis across clinical and food-safety testing. Its products include Clear Dx for oncology research (solid tumor sequencing, liquid biopsy, and fusion detection), Clear Ix for infectious disease a

minimal 13.0 / 100 0 APIs View provider profile →

Company Genomics Sequencing Infectious Disease Food Safety Oncology

Clearlabs is an API provider whose private shares are listed on 1 secondary market: EquityZen.

Where It Trades

EZ EquityZen View listing →

Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.